These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9607537)
1. Improved survival in patients with rectal cancer: a population-based register study. Dahlberg M; Påhlman L; Bergström R; Glimelius B Br J Surg; 1998 Apr; 85(4):515-20. PubMed ID: 9607537 [TBL] [Abstract][Full Text] [Related]
2. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Kapiteijn E; Putter H; van de Velde CJ; Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680 [TBL] [Abstract][Full Text] [Related]
3. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
4. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ; Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835 [TBL] [Abstract][Full Text] [Related]
6. Improved survival in cancer of the colon and rectum in Sweden. Birgisson H; Talbäck M; Gunnarsson U; Påhlman L; Glimelius B Eur J Surg Oncol; 2005 Oct; 31(8):845-53. PubMed ID: 15979269 [TBL] [Abstract][Full Text] [Related]
7. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Rutten H; den Dulk M; Lemmens V; Nieuwenhuijzen G; Krijnen P; Jansen-Landheer M; van de Poll Franse L; Coebergh JW; Martijn H; Marijnen C; van de Velde C Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242 [TBL] [Abstract][Full Text] [Related]
8. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. Folkesson J; Birgisson H; Pahlman L; Cedermark B; Glimelius B; Gunnarsson U J Clin Oncol; 2005 Aug; 23(24):5644-50. PubMed ID: 16110023 [TBL] [Abstract][Full Text] [Related]
9. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome. Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244 [TBL] [Abstract][Full Text] [Related]
10. Gender differences in the treatment of rectal cancer: a population based study. Martling A; Granath F; Cedermark B; Johansson R; Holm T Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417 [TBL] [Abstract][Full Text] [Related]
11. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237 [TBL] [Abstract][Full Text] [Related]
12. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780 [TBL] [Abstract][Full Text] [Related]
13. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487 [TBL] [Abstract][Full Text] [Related]
14. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. Birgisson H; Påhlman L; Gunnarsson U; Glimelius B; J Clin Oncol; 2005 Dec; 23(34):8697-705. PubMed ID: 16314629 [TBL] [Abstract][Full Text] [Related]
15. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment. van Gijn W; Krijnen P; Lemmens VE; den Dulk M; Putter H; van de Velde CJ Eur J Surg Oncol; 2010 Apr; 36(4):340-4. PubMed ID: 19944552 [TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes after total mesorectal excision for rectal cancer. Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534 [TBL] [Abstract][Full Text] [Related]
17. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
19. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804 [TBL] [Abstract][Full Text] [Related]